Heidelberg Pharma AG Stock
Price
Target price
€2.45
€2.45
-1.620%
-0.04
-1.620%
-
04.10.24 / Tradegate
WKN: A11QVV / Name: Heidelberg Pharma / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Heidelberg Pharma
sharewise wants to provide you with the best news and tools for Heidelberg Pharma, so we directly link to the best financial data sources.
Financials
News
EQS-News: Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
EQS-News: Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
EQS-News: Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
EQS-News: Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
EQS-News: Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
EQS-News: Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
EQS-News: Heidelberg Pharma reports on the results of the Annual General Meeting 2024
EQS-News: Heidelberg Pharma reports on the results of the Annual General Meeting 2024
EQS-Adhoc: Heidelberg Pharma AG announces updated guidance
EQS-Adhoc: Heidelberg Pharma AG announces updated guidance
EQS-News: Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024
EQS-News: Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024
EQS-News: Heidelberg Pharma to host R&D Webinar following novel data presented at AACR
EQS-News: Heidelberg Pharma to host R&D Webinar following novel data presented at AACR